Dr. Matthew P. Deek, MD | New Brunswick ...

Dr. Matthew P Deek, MD

Claim this profile

Rutgers Cancer Institute of New Jersey

Studies Pancreatic Cancer
Studies Bone Cancer
6 reported clinical trials
12 drugs studied

Affiliated Hospitals

Image of trial facility.

Rutgers Cancer Institute Of New Jersey

Image of trial facility.

RWJBarnabas Health - Robert Wood Johnson University Hospital

Clinical Trials Matthew P Deek, MD is currently running

Image of trial facility.

Peposertib + Radiation Therapy

for Pancreatic Cancer

This phase I/II trial studies the safety, side effects and best dose of M3814 and to see how well it works when given together with radiation therapy in treating patients with pancreatic cancer that has spread to nearby tissue or lymph nodes (locally advanced). M3814 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects. Giving M3814 and hypofractionated radiation therapy together may be safe, tolerable and/or more effective than radiation therapy alone in treating patients with locally advanced pancreatic cancer.

Recruiting

0 awards

Phase 1 & 2

3 criteria

Image of trial facility.

MRI Monitoring vs. Preventive Brain Radiation

for Small Cell Lung Cancer

This phase III trial studies magnetic resonance imaging (MRI) surveillance and prophylactic cranial irradiation (PCI) to see how well they work compared to MRI surveillance alone in treating patients with small cell lung cancer. MRI scans are used to monitor the possible spread of the cancer with an MRI machine over time. PCI is radiation therapy that is delivered to the brain in hopes of preventing spread of cancer into the brain. The use of brain MRI alone may reduce side effects of receiving PCI and prolong patients' lifespan. Monitoring with MRI scans alone (delaying radiation until the actual spread of the cancer) may be at least as good as the combination of PCI with MRI scans.

Recruiting

2 awards

Phase 3

22 criteria

More about Matthew P Deek, MD

Clinical Trial Related

2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Matthew P Deek, MD has experience with

  • EXTERNAL BEAM RADIATION
  • AN0025
  • Capecitabine
  • Fluorouracil
  • Intensity-Modulated Radiation Therapy
  • Mitomycin

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Matthew P Deek, MD specialize in?

Is Matthew P Deek, MD currently recruiting for clinical trials?

Are there any treatments that Matthew P Deek, MD has studied deeply?

What is the best way to schedule an appointment with Matthew P Deek, MD?

What is the office address of Matthew P Deek, MD?

Is there any support for travel costs?